Surgalign Holdings, Inc. (SRGA): Price and Financial Metrics

Surgalign Holdings, Inc. (SRGA): $4.08

0.04 (+0.99%)

POWR Rating

Component Grades














  • Value is the dimension where SRGA ranks best; there it ranks ahead of 75.87% of US stocks.
  • SRGA's strongest trending metric is Growth; it's been moving down over the last 103 days.
  • SRGA ranks lowest in Stability; there it ranks in the 10th percentile.

SRGA Stock Summary

  • Over the past twelve months, SRGA has reported earnings growth of 606.46%, putting it ahead of 97.24% of US stocks in our set.
  • The volatility of SURGALIGN HOLDINGS INC's share price is greater than that of 99.4% US stocks with at least 200 days of trading history.
  • SURGALIGN HOLDINGS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -66.13%, greater than the shareholder yield of only 7.19% of stocks in our set.
  • Stocks that are quantitatively similar to SRGA, based on their financial statements, market capitalization, and price volatility, are XRX, TG, HAS, CBT, and EHTH.
  • SRGA's SEC filings can be seen here. And to visit SURGALIGN HOLDINGS INC's official web site, go to

SRGA Valuation Summary

  • SRGA's EV/EBIT ratio is -0.1; this is 100.9% lower than that of the median Healthcare stock.
  • Over the past 243 months, SRGA's EV/EBIT ratio has gone up 5.6.

Below are key valuation metrics over time for SRGA.

Stock Date P/S P/B P/E EV/EBIT
SRGA 2022-08-23 0.3 1.4 -0.5 -0.1
SRGA 2022-08-22 0.3 1.4 -0.5 -0.2
SRGA 2022-08-19 0.3 1.4 -0.5 -0.2
SRGA 2022-08-18 0.4 1.4 -0.5 -0.2
SRGA 2022-08-17 0.4 1.4 -0.5 -0.2
SRGA 2022-08-16 0.4 1.4 -0.5 -0.2

SRGA Growth Metrics

    The 4 year price growth rate now stands at 1.79%.
  • Its year over year cash and equivalents growth rate is now at -29.93%.
  • Its 2 year net cashflow from operations growth rate is now at -542.56%.
Over the past 15 months, SRGA's revenue has gone down $48,026,000.

The table below shows SRGA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 83.603 -38.054 -58.929
2022-03-31 87.814 -56.404 -69.433
2021-12-31 90.5 -51.792 -84.651
2021-09-30 94.857 -56.98 -139.329
2021-06-30 102.238 -119.596 -8.739
2021-03-31 131.629 -109.08 -31.111

SRGA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SRGA has a Quality Grade of C, ranking ahead of 26.03% of graded US stocks.
  • SRGA's asset turnover comes in at 0.676 -- ranking 55th of 186 Medical Equipment stocks.
  • AHPI, HSDT, and RMD are the stocks whose asset turnover ratios are most correlated with SRGA.

The table below shows SRGA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.676 0.618 -0.273
2021-03-31 0.686 0.522 -0.460
2020-12-31 0.420 0.568 -0.362
2020-09-30 0.794 0.536 -0.710
2020-06-30 0.707 0.535 -0.912
2020-03-31 0.658 0.556 -0.604

SRGA Price Target

For more insight on analysts targets of SRGA, see our SRGA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $3.36 Average Broker Recommendation 1.43 (Moderate Buy)

SRGA Stock Price Chart Interactive Chart >

Price chart for SRGA

SRGA Price/Volume Stats

Current price $4.08 52-week high $44.40
Prev. close $4.04 52-week low $2.95
Day low $3.93 Volume 1,401
Day high $4.08 Avg. volume 103,972
50-day MA $3.84 Dividend yield N/A
200-day MA $10.56 Market Cap 27.53M

Surgalign Holdings, Inc. (SRGA) Company Bio

Surgalign Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides medical technology solutions with focus on spine surgery and elevating clinical outcomes. Surgalign Holdings serves customers worldwide.

SRGA Latest News Stream

Event/Time News Detail
Loading, please wait...

SRGA Latest Social Stream

Loading social stream, please wait...

View Full SRGA Social Stream

Latest SRGA News From Around the Web

Below are the latest news stories about SURGALIGN HOLDINGS INC that investors may wish to consider to help them evaluate SRGA as an investment opportunity.

Surgalign Announces FDA 510(k) Clearance of the Cortera™ Spinal Fixation System – The Company’s New Flagship Posterior Fixation Platform

DEERFIELD, Ill., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced FDA 510(k) clearance of the CorteraTM Spinal Fixation System. This new flagship product from Surgalign is a key piece to the foundational portfolio designed to drive the Company’s future growth over the next 10 years and to enable market share gains in the estimated $2.

Yahoo | August 24, 2022

Surgalign Announces Global Settlement Agreement with Resolve Surgical Technologies and RTI Surgical, Inc.

Parties enter into new sole-source supply relationship, extended for two yearsDEERFIELD, Ill., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that effective August 5, 2022, the Company entered into a global settlement agreement with Pioneer Surgical Technology, Inc. d/b/a Resolve Surgical Technologies and RTI Surgical, Inc. (togethe

Yahoo | August 10, 2022

Surgalign Holdings, Inc. Announces Second Quarter 2022 Results and Reiterates Full Year 2022 Revenue Guidance Range

DEERFIELD, Ill., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced financial results for its 2022 second quarter ended June 30, 2022. 2022 Second Quarter Key Highlights and Subsequent Events: First successful surgical procedures utilizing the HOLO Portal™ Surgical Guidance System in Indiana and further expansion in Ohio with more site

Yahoo | August 9, 2022

Surgalign Names Paolo Amoruso Chief Legal Officer and Corporate Secretary

DEERFIELD, Ill., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced the appointment of Paolo Amoruso as its new General Counsel and Corporate Secretary, effective August 1, 2022. He previously served as Interim General Counsel of Surgalign, having joined the Company in April 2022. Commenting on today’s appointment, Terry Rich, President

Yahoo | August 4, 2022

Surgalign Reaches Settlement with the Securities and Exchange Commission on Matters Related to Prior Management Between 2015-2019

DEERFIELD, Ill., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) on August 3, 2022, concluding and resolving in its entirety the previously disclosed SEC investigation relating to activities that occurred between 2015 and 2019 by RTI Surgical Holdings, Inc., and RTI Surgical, Inc. and the prior management. As reflected in the SEC’s Order, those activities included pulling sales forward from f

Yahoo | August 3, 2022

Read More 'SRGA' Stories Here

SRGA Price Returns

1-mo -32.00%
3-mo -11.30%
6-mo -57.50%
1-year -90.62%
3-year -96.08%
5-year -96.94%
YTD -81.02%
2021 -67.29%
2020 -20.07%
2019 -25.95%
2018 -9.76%
2017 26.15%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6359 seconds.